JETEMA, Co., Ltd. (216080.KQ)
KRW 15130.0
(-2.64%)
KRW 15130.0
(-2.64%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 60 Billion KRW | -2.39% |
| 2022 | 61.46 Billion KRW | 29.64% |
| 2021 | 47.41 Billion KRW | 1387.45% |
| 2020 | 3.18 Billion KRW | -42.06% |
| 2019 | 5.5 Billion KRW | -19.78% |
| 2018 | 6.85 Billion KRW | 45.45% |
| 2017 | 4.71 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 100 Million KRW | -99.8% |
| 2024 Q1 | 50 Billion KRW | -16.67% |
| 2023 Q1 | 61.39 Billion KRW | -0.11% |
| 2023 FY | 60 Billion KRW | -2.39% |
| 2023 Q4 | 60 Billion KRW | 0.0% |
| 2023 Q3 | 60 Billion KRW | -2.17% |
| 2023 Q2 | 61.33 Billion KRW | -0.11% |
| 2022 Q4 | 61.46 Billion KRW | -0.22% |
| 2022 Q3 | 61.6 Billion KRW | -43.74% |
| 2022 Q2 | 109.48 Billion KRW | 91.08% |
| 2022 Q1 | 57.3 Billion KRW | 20.86% |
| 2022 FY | 61.46 Billion KRW | 29.64% |
| 2021 Q2 | 4.31 Billion KRW | 41.42% |
| 2021 Q4 | 47.41 Billion KRW | -1.43% |
| 2021 FY | 47.41 Billion KRW | 1387.45% |
| 2021 Q1 | 3.05 Billion KRW | -4.22% |
| 2021 Q3 | 48.09 Billion KRW | 1014.09% |
| 2020 Q1 | 5.35 Billion KRW | -2.74% |
| 2020 FY | 3.18 Billion KRW | -42.06% |
| 2020 Q3 | 3.72 Billion KRW | -6.89% |
| 2020 Q4 | 3.18 Billion KRW | -14.36% |
| 2020 Q2 | 3.99 Billion KRW | -25.29% |
| 2019 Q4 | 5.5 Billion KRW | 0.0% |
| 2019 FY | 5.5 Billion KRW | -19.78% |
| 2019 Q3 | - KRW | 0.0% |
| 2019 Q1 | - KRW | 0.0% |
| 2018 Q1 | - KRW | 0.0% |
| 2018 FY | 6.85 Billion KRW | 45.45% |
| 2017 FY | 4.71 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 17.93 Billion KRW | -234.575% |
| iNtRON Biotechnology, Inc. | 258.29 Million KRW | -23129.266% |
| BINEX Co., Ltd. | 5.57 Billion KRW | -975.586% |
| Bioneer Corporation | 12.5 Billion KRW | -380.0% |
| Anterogen.Co.,Ltd. | - KRW | -Infinity% |
| MEDIPOST Co., Ltd. | 6.99 Billion KRW | -757.765% |
| CrystalGenomics, Inc. | 29.88 Billion USD | -100.741% |
| Helixmith Co., Ltd | 151.68 Million KRW | -39456.962% |
| Chabiotech Co.,Ltd. | 95.06 Billion KRW | 36.887% |
| Medy-Tox Inc. | 1.22 Billion KRW | -4794.596% |
| Peptron, Inc. | 4.5 Billion KRW | -1233.333% |
| Amicogen, Inc. | 70.65 Billion KRW | 15.079% |
| Genexine, Inc. | 22.68 Billion KRW | -164.534% |
| HLB Therapeutics Co.,Ltd. | 1.84 Billion KRW | -3160.533% |
| LegoChem Biosciences, Inc. | 528.37 Million KRW | -11255.621% |
| ALTEOGEN Inc. | 1.24 Billion KRW | -4702.855% |
| PharmaResearch Co., Ltd. | 970.71 Million KRW | -6080.998% |
| SillaJen, Inc. | 8.13 Billion KRW | -637.477% |
| OliX Pharmaceuticals,Inc | 35.36 Billion KRW | -69.675% |
| Genomictree Inc. | 97.51 Million KRW | -61428.579% |
| MedPacto, Inc. | 1.68 Billion KRW | -3456.723% |
| D&D Pharmatech | 5.12 Billion KRW | -1071.733% |
| EASY BIO,Inc. | 30 Billion KRW | -100.0% |
| GI Innovation, Inc. | 2.9 Billion KRW | -1966.111% |